New patent expiration for Secura drug FARYDAK

Pharma
Copyright ©
DrugPatentWatch. Originally published at
New patent expiration for Secura drug FARYDAK

Annual Drug Patent Expirations for FARYDAK
Annual Drug Patent Expirations for FARYDAK

Farydak is a drug marketed by Secura and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

Drug patent litigation for FARYDAK.

This drug has one hundred and six patent family members in forty-eight countries.

The generic ingredient in FARYDAK is panobinostat lactate. One supplier is listed for this compound. Additional details are available on the panobinostat lactate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright ©
DrugPatentWatch. Originally published at
New patent expiration for Secura drug FARYDAK

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.